Hypha Labs, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
FUNI
Hypha Labs, INCHypha Labs, Inc. announced a change in its independent registered public accounting firm, dismissing Fruci & Associates II, PLLC and engaging Astra Audit and Advisory, LLC, though the previous auditor had raised going concern doubts.
OQB
FUNI
Hypha Labs, INCHypha Labs, Inc. adopts a new code of conduct and business ethics while also formalizing a consulting agreement with its Chairman, President, CEO, CFO, and Secretary.
OQB
FUNI
Hypha Labs, INCHypha Labs, Inc. has amended its Articles of Incorporation to significantly increase the number of authorized common and preferred shares.
OQB
FUNI
Hypha Labs, INCHypha Labs, Inc. sold 1,000 shares of Series C Preferred Stock to its CEO, A. Stone Douglass, for $0.10 per share, granting him majority voting power to approve an increase in authorized common and preferred shares.
OQB
FUNI
Hypha Labs, INCHypha Labs, Inc., formerly Digipath, Inc., has officially changed its name following the sale of its testing business on February 20, 2024.
OQB
FUNI
Hypha Labs, INCDigipath Inc. reports the resignation of its President, Todd Denkin, and the appointment of A. Stone Douglass as the new President and CEO, effective February 29, 2024.
OQB
FUNI
Hypha Labs, INCDigipath, Inc. has finalized the sale of substantially all assets of its subsidiary, Digipath Labs, Inc., to DPL NV LLC for a total cash consideration of $2.3 million, subject to certain adjustments.